Klaus - Dieter Albrecht has been appointed Managing Director of Synexus Germany. Klaus is responsible for the management of the eight Synexus dedicated clinical trial centres in Germany including new business and profitability. Synexus, which is based in Manchester, is the largest multinational organisation dedicated to the recruitment of patients and running of clinical trials at its own dedicated research centres.
Klaus has had extensive experience in the CRO marketplace with senior positions at Encorium and Pierrel as well as working with Schwarz pharma as head of contract management. He is a pharmacist by training.
Germany is a very important market for Synexus with more clinics than any other country in Synexus’ network of 25 clinical trial centres, across Europe and Africa.
Dr Christophe Berthoux, CEO of Synexus commented: “We are delighted to welcome Klaus on board. He has a lot of experience in our industry and will be a great new addition to our strengthened management team. He will be responsible for driving our growth in this very important market.”
More information about Synexus can be found at www.synexus.com